BRPI0907439A2 - Azabicyclic carboxamides derivative, their preparation and their therapeutic application - Google Patents
Azabicyclic carboxamides derivative, their preparation and their therapeutic applicationInfo
- Publication number
- BRPI0907439A2 BRPI0907439A2 BRPI0907439-2A BRPI0907439A BRPI0907439A2 BR PI0907439 A2 BRPI0907439 A2 BR PI0907439A2 BR PI0907439 A BRPI0907439 A BR PI0907439A BR PI0907439 A2 BRPI0907439 A2 BR PI0907439A2
- Authority
- BR
- Brazil
- Prior art keywords
- azabicyclic
- preparation
- therapeutic application
- carboxamides
- derivative
- Prior art date
Links
- 150000003857 carboxamides Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0800310A FR2926556B1 (en) | 2008-01-22 | 2008-01-22 | N-AZABICYCLIC CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
| PCT/FR2009/000053 WO2009112679A1 (en) | 2008-01-22 | 2009-01-20 | Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0907439A2 true BRPI0907439A2 (en) | 2015-08-04 |
Family
ID=39832257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0907439-2A BRPI0907439A2 (en) | 2008-01-22 | 2009-01-20 | Azabicyclic carboxamides derivative, their preparation and their therapeutic application |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US8394820B2 (en) |
| EP (1) | EP2235016B1 (en) |
| JP (1) | JP5490723B2 (en) |
| KR (1) | KR20100105782A (en) |
| CN (1) | CN101977910B (en) |
| AR (1) | AR070208A1 (en) |
| AU (1) | AU2009224534B2 (en) |
| BR (1) | BRPI0907439A2 (en) |
| CA (1) | CA2712629C (en) |
| CL (1) | CL2009000120A1 (en) |
| CO (1) | CO6280508A2 (en) |
| CR (1) | CR11547A (en) |
| DO (1) | DOP2010000215A (en) |
| EA (1) | EA201070873A1 (en) |
| EC (1) | ECSP10010356A (en) |
| FR (1) | FR2926556B1 (en) |
| HN (1) | HN2010001461A (en) |
| IL (1) | IL207080A0 (en) |
| MA (1) | MA32090B1 (en) |
| MX (1) | MX2010007976A (en) |
| NI (1) | NI201000125A (en) |
| NZ (1) | NZ587014A (en) |
| PE (2) | PE20130230A1 (en) |
| TN (1) | TN2010000295A1 (en) |
| TW (1) | TW200936584A (en) |
| UA (1) | UA102088C2 (en) |
| UY (1) | UY31608A1 (en) |
| WO (1) | WO2009112679A1 (en) |
| ZA (1) | ZA201005201B (en) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA201070876A1 (en) * | 2008-01-22 | 2011-04-29 | Такеда Фармасьютикал Компани Лимитед | TRICYCLIC COMPOUNDS, HAVING ANTAGONISTIC ACTIVITY WITH RESPECT TO CORTICOTROPIN-RELAXING FACTOR, AND THEIR PHARMACEUTICAL COMPOSITIONS |
| FR2926554B1 (en) * | 2008-01-22 | 2010-03-12 | Sanofi Aventis | AZABICYCLIC CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF |
| WO2011036127A1 (en) * | 2009-09-24 | 2011-03-31 | F. Hoffmann-La Roche Ag | Imidazopyridine or imidazopyrimidine derivatives as phosphodiesterase 10a inhibitors |
| US20120220581A1 (en) | 2009-10-30 | 2012-08-30 | Janssen-Cilag, S.A. | IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS |
| WO2011079076A1 (en) * | 2009-12-21 | 2011-06-30 | Array Biopharma Inc. | Substituted n-(1h-indazol-4-yl)imidazo[1, 2-a]pyridine-3- carboxamide compounds as cfms inhibitors |
| AR080754A1 (en) | 2010-03-09 | 2012-05-09 | Janssen Pharmaceutica Nv | IMIDAZO DERIVATIVES (1,2-A) PIRAZINA AND ITS USE AS PDE10 INHIBITORS |
| US8410117B2 (en) * | 2010-03-26 | 2013-04-02 | Hoffmann-La Roche Inc. | Imidazopyrimidine derivatives |
| TWI527814B (en) | 2010-12-16 | 2016-04-01 | 健生科學愛爾蘭無限公司 | Azabenzimidazoles as respiratory syncytial virus antiviral agents |
| TWI515187B (en) * | 2010-12-16 | 2016-01-01 | 健生科學愛爾蘭無限公司 | Indoles as respiratory syncytial virus antiviral agents |
| TWI541241B (en) * | 2010-12-16 | 2016-07-11 | 健生科學愛爾蘭無限公司 | Imidazopyridines as respiratory syncytial virus antiviral agents |
| TWI501967B (en) | 2010-12-16 | 2015-10-01 | Janssen R&D Ireland | Azaindoles as respiratory syncytial virus antiviral agents |
| US10604523B2 (en) | 2011-06-27 | 2020-03-31 | Janssen Pharmaceutica Nv | 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives |
| EA037918B1 (en) | 2011-12-21 | 2021-06-07 | Новира Терапьютикс, Инк. | Hepatitis b antiviral agents |
| PT2864323T (en) | 2012-06-15 | 2017-07-14 | Janssen Sciences Ireland Uc | 1,3-dihydro-2h-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents |
| JP6426603B2 (en) | 2012-06-26 | 2018-11-21 | ヤンセン ファーマシューティカ エヌ．ベー． | A PDE2 inhibitor such as a 1-aryl-4-methyl- [1,2,4] triazolo [4,3-a] -quinoxaline compound and a PDE10 inhibitor for use in the treatment of a neurological or metabolic disorder combination |
| CN104411314B (en) | 2012-07-09 | 2017-10-20 | 詹森药业有限公司 | The inhibitor of phosphodiesterase 10 |
| SG10201605291WA (en) | 2012-08-28 | 2016-08-30 | Janssen Sciences Ireland Uc | Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b |
| CA2899352A1 (en) * | 2013-01-30 | 2014-08-07 | Bayer Pharma Aktiengesellschaft | Amidoimidazopyridazines as mknk-1 kinase inhibitors |
| HUE034820T2 (en) | 2013-02-28 | 2018-02-28 | Janssen Sciences Ireland Uc | Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b |
| BR112015025052A2 (en) | 2013-04-03 | 2021-07-06 | Janssen Sciences Ireland Uc | n-phenyl carboxamide derivatives and their use as medicines for the treatment of hepatitis b |
| PL2997019T3 (en) | 2013-05-17 | 2019-03-29 | Janssen Sciences Ireland Uc | Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis b |
| JO3603B1 (en) | 2013-05-17 | 2020-07-05 | Janssen Sciences Ireland Uc | Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b |
| AP2015008968A0 (en) | 2013-07-25 | 2015-12-31 | Janssen Sciences Ireland Uc | Glyoxamide substituted pyrrolamide derivatives andthe use thereof as medicaments for the treatment of hepatitis b |
| EP3060547B1 (en) | 2013-10-23 | 2017-10-11 | Janssen Sciences Ireland UC | Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b |
| US9169212B2 (en) | 2014-01-16 | 2015-10-27 | Novira Therapeutics, Inc. | Azepane derivatives and methods of treating hepatitis B infections |
| US10392349B2 (en) | 2014-01-16 | 2019-08-27 | Novira Therapeutics, Inc. | Azepane derivatives and methods of treating hepatitis B infections |
| ES2792848T3 (en) | 2014-02-05 | 2020-11-12 | Novira Therapeutics Inc | Combination therapy for the treatment of HBV infections |
| EA035848B1 (en) | 2014-02-06 | 2020-08-20 | Янссен Сайенсиз Айрлэнд Юси | Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b |
| PE20170682A1 (en) | 2014-08-04 | 2017-06-15 | Nuevolution As | PYRIMIDINE DERIVATIVES SUBSTITUTED WITH OPTIONALLY CONDENSED HETERO CYCLYL USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOIMMUNE DISEASES |
| EP3271019A1 (en) | 2015-03-19 | 2018-01-24 | Novira Therapeutics Inc. | Azocane and azonane derivatives and methods of treating hepatitis b infections |
| US10875876B2 (en) | 2015-07-02 | 2020-12-29 | Janssen Sciences Ireland Uc | Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B |
| WO2017059059A1 (en) | 2015-09-29 | 2017-04-06 | Novira Therapeutics, Inc. | Crystalline forms of a hepatitis b antiviral agent |
| SG11201808949SA (en) | 2016-04-15 | 2018-11-29 | Novira Therapeutics Inc | Combinations and methods comprising a capsid assembly inhibitor |
| US10071079B2 (en) | 2016-06-29 | 2018-09-11 | Bristol-Myers Squibb Company | [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds |
| WO2019028301A1 (en) | 2017-08-04 | 2019-02-07 | Bristol-Myers Squibb Company | [1,2,4]TRIAZOLO[4,3-a]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS |
| JP7104775B2 (en) | 2017-08-04 | 2022-07-21 | ブリストル－マイヤーズ スクイブ カンパニー | Substituted indole compounds useful as inhibitors of TLR7 / 8/9 |
| WO2019116302A1 (en) | 2017-12-13 | 2019-06-20 | Lupin Limited | Substituted bicyclic heterocyclic compounds as prmt5 inhibitors |
| US10973801B2 (en) | 2018-03-14 | 2021-04-13 | Janssen Sciences Ireland Unlimited Company | Capsid assembly modulator dosing regimen |
| TW202045499A (en) | 2019-02-22 | 2020-12-16 | 愛爾蘭商健生科學愛爾蘭無限公司 | Amide derivatives useful in the treatment of hbv infection or hbv-induced diseases |
| CA3132554A1 (en) | 2019-05-06 | 2020-11-12 | Bart Rudolf Romanie Kesteleyn | Amide derivatives useful in the treatment of hbv infection or hbv-induced diseases |
| EP4076657A1 (en) | 2019-12-20 | 2022-10-26 | Nuevolution A/S | Compounds active towards nuclear receptors |
| US11780843B2 (en) | 2020-03-31 | 2023-10-10 | Nuevolution A/S | Compounds active towards nuclear receptors |
| US11613532B2 (en) | 2020-03-31 | 2023-03-28 | Nuevolution A/S | Compounds active towards nuclear receptors |
| CN113280838B (en) * | 2021-05-17 | 2022-10-11 | 武汉纺织大学 | Full-fiber-based self-powered sensor |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0322153A3 (en) * | 1987-12-21 | 1990-08-16 | Pfizer Inc. | Heterocyclic oxophtalazinyl acetic acids |
| FR2874015B1 (en) * | 2004-08-05 | 2006-09-15 | Sanofi Synthelabo | N- (1H-INDOLYL) -1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE |
| FR2880625B1 (en) * | 2005-01-07 | 2007-03-09 | Sanofi Aventis Sa | N- (HETEROARYL) -1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE |
| FR2888847B1 (en) * | 2005-07-22 | 2007-08-31 | Sanofi Aventis Sa | N- (HETERIARYL) -1-HETEORARYLALKYL-1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC APPLICATION |
| FR2888848B1 (en) * | 2005-07-22 | 2007-09-28 | Sanofi Aventis Sa | N- (ARYLALKYL) -1H-PYRRROLOPYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE |
| FR2897061B1 (en) * | 2006-02-03 | 2010-09-03 | Sanofi Aventis | TRICYCLIC N-HETEROARYL-CARBOXAMIDE DERIVATIVES CONTAINING A BENZIMIDAZOLE PATTERN, THEIR PREPARATION AND THEIR THERAPEUTIC USE. |
| FR2904316B1 (en) * | 2006-07-31 | 2008-09-05 | Sanofi Aventis Sa | N- (AMINO-HETEROARYL) -1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE. |
| FR2910473B1 (en) * | 2006-12-26 | 2009-02-13 | Sanofi Aventis Sa | N- (AMINO-HETEROARYL) -1H-PYRROLOPYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE. |
| FR2911604B1 (en) * | 2007-01-19 | 2009-04-17 | Sanofi Aventis Sa | N- (HETEROARYL-1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE |
| FR2911605B1 (en) * | 2007-01-19 | 2009-04-17 | Sanofi Aventis Sa | PYRROLOPYRIDINE-2-CARBOWAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE |
-
2008
- 2008-01-22 FR FR0800310A patent/FR2926556B1/en not_active Expired - Fee Related
-
2009
- 2009-01-20 AU AU2009224534A patent/AU2009224534B2/en not_active Ceased
- 2009-01-20 EP EP09720539.7A patent/EP2235016B1/en active Active
- 2009-01-20 CA CA2712629A patent/CA2712629C/en not_active Expired - Fee Related
- 2009-01-20 JP JP2010543540A patent/JP5490723B2/en not_active Expired - Fee Related
- 2009-01-20 CN CN2009801100019A patent/CN101977910B/en not_active Expired - Fee Related
- 2009-01-20 WO PCT/FR2009/000053 patent/WO2009112679A1/en active Application Filing
- 2009-01-20 AR ARP090100168A patent/AR070208A1/en not_active Application Discontinuation
- 2009-01-20 PE PE2012002297A patent/PE20130230A1/en not_active Application Discontinuation
- 2009-01-20 UA UAA201010236A patent/UA102088C2/en unknown
- 2009-01-20 BR BRPI0907439-2A patent/BRPI0907439A2/en active Search and Examination
- 2009-01-20 EA EA201070873A patent/EA201070873A1/en unknown
- 2009-01-20 PE PE2009000066A patent/PE20091403A1/en not_active Application Discontinuation
- 2009-01-20 MX MX2010007976A patent/MX2010007976A/en active IP Right Grant
- 2009-01-20 KR KR1020107018564A patent/KR20100105782A/en not_active Application Discontinuation
- 2009-01-20 NZ NZ587014A patent/NZ587014A/en not_active IP Right Cessation
- 2009-01-21 TW TW098102261A patent/TW200936584A/en unknown
- 2009-01-21 CL CL2009000120A patent/CL2009000120A1/en unknown
- 2009-01-22 UY UY031608A patent/UY31608A1/en not_active Application Discontinuation
-
2010
- 2010-06-23 TN TN2010000295A patent/TN2010000295A1/en unknown
- 2010-06-29 CR CR11547A patent/CR11547A/en not_active Application Discontinuation
- 2010-07-13 DO DO2010000215A patent/DOP2010000215A/en unknown
- 2010-07-19 EC EC2010010356A patent/ECSP10010356A/en unknown
- 2010-07-19 IL IL207080A patent/IL207080A0/en unknown
- 2010-07-21 US US12/840,664 patent/US8394820B2/en not_active Expired - Fee Related
- 2010-07-21 ZA ZA2010/05201A patent/ZA201005201B/en unknown
- 2010-07-21 HN HN2010001461A patent/HN2010001461A/en unknown
- 2010-07-21 NI NI201000125A patent/NI201000125A/en unknown
- 2010-07-22 CO CO10089478A patent/CO6280508A2/en not_active Application Discontinuation
- 2010-08-17 MA MA33098A patent/MA32090B1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0907439A2 (en) | Azabicyclic carboxamides derivative, their preparation and their therapeutic application | |
| BRPI0907381A2 (en) | Azabicyclic carboxamide derivatives, their preparation and their therapeutic application. | |
| BRPI1012857A2 (en) | cyclopenta [c] pyrrol-2-carboxylate derivatives, their preparation and their therapeutic application | |
| BRPI0810440A2 (en) | Triazolopyridine-CARBOXAMIDES AND Triazolopyrimidine-CARBOXAMIDES DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTIC | |
| BRPI0810412A2 (en) | PYRIDINE-CARBOXAMIDES AND Triazole PYRIMIDINE-CARBOXAMIDES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | |
| BRPI0915438A2 (en) | pyridine pyridinones derivatives, their preparation and their therapeutic application. | |
| GB0817121D0 (en) | Anti-fungal therapy | |
| BRPI1013553A2 (en) | nicotinamide derivatives, their preparation and their therapeutic application as anticancer | |
| IL219888A0 (en) | Pyridine-pyridinone derivatives, preparation and therapeutic use thereof | |
| BRPI0917464A2 (en) | polysubstituted azetidine compounds, their preparation and their therapeutic application | |
| BRPI0907578A2 (en) | 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, their preparation and their therapeutic application | |
| BRPI0920743A2 (en) | therapeutic ribonucleases | |
| BRPI0810430A2 (en) | PYRIDINE Triazole derivatives - CARBOXAMIDES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | |
| BRPI0818598A2 (en) | therapeutic agents - 802 | |
| BRPI0923875A2 (en) | 2-Pyridin-2-yl-pyrazol-3 (2h) -one derivatives, their preparation and their therapeutic application. | |
| BR112012000104A2 (en) | pyrazole derivatives, their preparation and their application in therapeutic | |
| DK2240482T3 (en) | CYCLE AZAINDOL-3 CARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS MEDICINES | |
| BRPI0923182A2 (en) | 6-cyclamino-2,3-di-pyridinyl-imidazo [1,2-b] pyridazine derivatives, their preparation and their preparation and their therapeutic application | |
| DK2310383T3 (en) | 2-oxo-alkyl-1-piperazine-2-undivatives, their preparation and therapeutic use thereof | |
| BRPI0822054A2 (en) | Azetidine derivatives, their preparation and their therapeutic application | |
| BRPI1013903A2 (en) | therapeutic treatments using centaquin | |
| BRPI0806969A2 (en) | AZABICYCLALCANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | |
| BRPI0814756A2 (en) | tricyclic n-heteroaryl carboxamides derivatives, their preparation and their therapeutic application | |
| BRPI0821426A2 (en) | Compounds of n-phenylimidazo [1,2-a] pyridine-2-carboxamides, their preparation and their therapeutic application. | |
| BRPI0816239A2 (en) | Quinoline and Naphthalene Therapeutic Derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2497 DE 13-11-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |